Company Announcements
Director/PDMR Shareholding
Related Companies
By LSE RNS
Hikma Pharmaceuticals PLC - Vesting of LTIP
LONDON, 12 June 2017: Hikma Pharmaceuticals PLC (LSE: HIK) (NasdaqDubai: HIK) ("Hikma") (LEI: 549300BNS685UXH4JI75) announces that the following Persons Discharging Managerial Responsibility ("PDMR") have received shares as a result of the vesting of their conditional share awards on 11 June 2017 under the 2005 Long Term Incentive Plan ("LTIP") which was completed on 12 June 2017. These awards were automatically exercised by operation of the conditional award and vesting process. The exercise price under the LTIP is £nil.
Notification and public disclosure of transactions by persons discharging managerial responsibilities
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) |
Name |
Khalid Nabilsi |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Chief Financial Officer |
|
b) |
Initial notification /Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Hikma Pharmaceuticals PLC |
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
b) |
Nature of the transaction
|
Shares acquired from vesting of the conditional awards on 11 June 2017 under the LTIP. |
|
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 12,842 |
|
d) |
Aggregated information |
N/A |
|
e) |
Date of the transaction |
12 June 2017 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) |
Name |
Riad Mishlawi |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
EU Vice President and Global Head of Injectables |
|
b) |
Initial notification /Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Hikma Pharmaceuticals PLC |
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
b) |
Nature of the transaction
|
Shares acquired from vesting of the conditional awards on 11 June 2017 under the LTIP. |
|
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 12,521 |
|
d) |
Aggregated information |
N/A |
|
e) |
Date of the transaction |
12 June 2017 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) |
Name |
Michael Raya |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
CEO of West-Ward Pharmaceuticals |
|
b) |
Initial notification /Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Hikma Pharmaceuticals PLC |
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
b) |
Nature of the transaction
|
Shares acquired from vesting of the conditional awards on 11 June 2017 under the LTIP. |
|
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 19,244 |
|
d) |
Aggregated information |
N/A |
|
e) |
Date of the transaction |
12 June 2017 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) |
Name |
Bassam Kanaan |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Chief Strategy and Corporate Development Officer |
|
b) |
Initial notification /Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Hikma Pharmaceuticals PLC |
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
b) |
Nature of the transaction
|
Shares acquired from vesting of the conditional awards on 11 June 2017 under the LTIP. |
|
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 20,341 |
|
d) |
Aggregated information |
N/A |
|
e) |
Date of the transaction |
12 June 2017 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
|
1 |
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a) |
Name |
Majda Labadi |
|
2 |
Reason for the notification |
|
|
a) |
Position/status |
Corporate Vice President for Human Resources and Head of Operations, MENA |
|
b) |
Initial notification /Amendment |
Initial notification |
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a) |
Name |
Hikma Pharmaceuticals PLC |
|
b) |
LEI |
549300BNS685UXH4JI75 |
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a) |
Description of the financial instrument, type of instrument and identification code |
Description: Ordinary shares of 10 pence each (Shares) ID Code: GB00B0LCW083 |
|
b) |
Nature of the transaction
|
Shares acquired from vesting of the conditional awards on 11 June 2017 under the LTIP. |
|
c) |
Price(s) and volume(s) |
Price(s): £nil Volume(s): 9,879 |
|
d) |
Aggregated information |
N/A |
|
e) |
Date of the transaction |
12 June 2017 |
|
f) |
Place of the transaction |
London Stock Exchange (XLON) |
This information is provided by RNS
You are here: news > regulatory news
10 Lower Thames St,
London EC3R 6EN